Bijan Ahvazi

Array ( [id] => 6395678 [patent_doc_number] => 20100178317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'Lens Care Solutions with Hyaluronic Acid' [patent_app_type] => utility [patent_app_number] => 12/684363 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8431 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20100178317.pdf [firstpage_image] =>[orig_patent_app_number] => 12684363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754794 [patent_doc_number] => 20120027842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'TOPICAL FORMULATIONS OF FLAP INHIBITORS FOR ADMINISTRATION TO AN EYE' [patent_app_type] => utility [patent_app_number] => 13/141673 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16702 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027842.pdf [firstpage_image] =>[orig_patent_app_number] => 13141673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7779224 [patent_doc_number] => 20120041356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'PHOTODYNAMIC THERAPY FOR CONDITIONS OF THE EYE' [patent_app_type] => utility [patent_app_number] => 13/140411 [patent_app_country] => US [patent_app_date] => 2009-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 17035 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041356.pdf [firstpage_image] =>[orig_patent_app_number] => 13140411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296018 [patent_doc_number] => 20100160342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Compositions of Topical Ocular Solutions to Deliver Effective Concentrations of Active Agent to the Posterior Segment of the Eye' [patent_app_type] => utility [patent_app_number] => 12/633322 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4699 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160342.pdf [firstpage_image] =>[orig_patent_app_number] => 12633322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11749176 [patent_doc_number] => 09707173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Pharmaceutical suspension' [patent_app_type] => utility [patent_app_number] => 12/630399 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5937 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12630399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248831 [patent_doc_number] => 20100137252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Ophthalmic composition' [patent_app_type] => utility [patent_app_number] => 12/591784 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12214 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137252.pdf [firstpage_image] =>[orig_patent_app_number] => 12591784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9575372 [patent_doc_number] => 08765787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen' [patent_app_type] => utility [patent_app_number] => 12/622509 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12413 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12622509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236409 [patent_doc_number] => 20100267684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'USE OF BIOLOGICAL SURFACTANT AS ANTI-INFLAMMATORY AGENT AND TISSUE PRESERVATIVE SOLUTION' [patent_app_type] => utility [patent_app_number] => 12/619644 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 6583 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267684.pdf [firstpage_image] =>[orig_patent_app_number] => 12619644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10548374 [patent_doc_number] => 09272985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Antibacterial hydroxyphenyl compound' [patent_app_type] => utility [patent_app_number] => 13/393666 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6673 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355369 [patent_doc_number] => 08673902 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Method of treating otic infections with moxifloxacin compositions' [patent_app_type] => utility [patent_app_number] => 12/611510 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2558 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12611510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596525 [patent_doc_number] => 20100048608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Histone Deacetylase Inhibitors for the Treatment of Ocular Neovascular or Edematous Disorders and Diseases' [patent_app_type] => utility [patent_app_number] => 12/609873 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3189 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048608.pdf [firstpage_image] =>[orig_patent_app_number] => 12609873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216379 [patent_doc_number] => 08629179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Methods and devices for providing prolonged drug therapy' [patent_app_type] => utility [patent_app_number] => 12/581699 [patent_app_country] => US [patent_app_date] => 2009-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 11567 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12581699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495954 [patent_doc_number] => 20100093845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'COMPOSITION AND METHOD FOR TREATING DRY EYE SYNDROME' [patent_app_type] => utility [patent_app_number] => 12/576834 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3094 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093845.pdf [firstpage_image] =>[orig_patent_app_number] => 12576834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6360876 [patent_doc_number] => 20100087540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/571672 [patent_app_country] => US [patent_app_date] => 2009-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6656 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087540.pdf [firstpage_image] =>[orig_patent_app_number] => 12571672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014885 [patent_doc_number] => 20110223177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'TREATMENT OF FIBROTIC EYE DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/063132 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6916 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223177.pdf [firstpage_image] =>[orig_patent_app_number] => 13063132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603546 [patent_doc_number] => 20100063017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Ophthalmic Suspension for Ocular Use' [patent_app_type] => utility [patent_app_number] => 12/554514 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4927 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063017.pdf [firstpage_image] =>[orig_patent_app_number] => 12554514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6618059 [patent_doc_number] => 20100003334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Combination of loteprednol etabonate and tobramycin for topical ophthalmic use' [patent_app_type] => utility [patent_app_number] => 12/584186 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3892 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003334.pdf [firstpage_image] =>[orig_patent_app_number] => 12584186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6360962 [patent_doc_number] => 20100087550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'Formulations with a Tertiary Amine Oxide' [patent_app_type] => utility [patent_app_number] => 12/542739 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5858 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087550.pdf [firstpage_image] =>[orig_patent_app_number] => 12542739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6468099 [patent_doc_number] => 20100040669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Non-Invasive Ocular Delivery of Rapamycin' [patent_app_type] => utility [patent_app_number] => 12/540271 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5952 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040669.pdf [firstpage_image] =>[orig_patent_app_number] => 12540271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144689 [patent_doc_number] => 20110130388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'PROPHYLACTIC OR THERAPEUTIC AGENT FOR AXIAL MYOPIA' [patent_app_type] => utility [patent_app_number] => 13/002848 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5350 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130388.pdf [firstpage_image] =>[orig_patent_app_number] => 13002848 [rel_patent_id] =>[rel_patent_doc_number] =>)